Skip to main content
. 2018 Apr 26;78(4):382–399. doi: 10.1055/a-0582-0122
Consensus-based Recommendation 3.E8
Expert consensus Level of consensus +++
If risk factors are present, the following measures must be taken:
  • Adequate venous access for every woman in labour, adequate intravenous access in case of complications of bleeding

  • Uterotonics must be available (oxytocin, e.g. Syntocinon ® ), prostaglandins (e.g. sulprostone: Nalador ® ), misoprostol (Cytotec ® , off-label use)

  • Check logistics:

    • Check availability of emergency laboratory tests (complete blood count, blood gas analysis [BGA], aPTT, prothrombin time [PT] or INR, antithrombin [AT], fibrinogen, possibly thromboelastography or thromboelastometry [ROTEM])

    • Obstetrician and anaesthesiologist must be on site, experienced obstetrician and experienced anaesthesiologist on call

    • Check availability of blood products: cross-matching, ordering of packed red blood cells, fresh frozen plasma and platelets

    • Check availability of haemostatic agents (tranexamic acid [Cyclokapron ® ], fibrinogen [Haemocomplettan ® ], factor XIII [Fibrogammin ® ], recombinant activated factor VII a [rFVIIa, NovoSeven ® , off-label use]).